Dedicated to his patients and the prospect of finding cures for cancer, Dr. Jeff Sharman, a medical oncologist practicing at Willamette Valley Cancer Institute and Research Center, was recently appointed associate chair of blood cancer research for US Oncology, the nation’s premier oncology services company.
By accepting this national appointment, those in Lane County will now have greater access to lymphoma and leukemia drugs through clinical trials, offering new hope for patients right here in our community...
Like an ocean wave crashing into shore, Connie Huffman knows the shock, disbelief and sense of injustice that washes over you when you’re told a loved one has cancer. Instead of letting it overcome her, Connie grabbed hold of a single word that has served as her buoy when she feels like she’s struggling in a sea of uncertainty.
“Believe,” she says. “I have to ‘believe.’”
She and her husband, Jim, had done everything right. She’s 49; he’s 51. At their ages, they both needed regular cancer screenings and had them. But nine months after an all-clear screening, Jim was diagnosed with prostate cancer that had rapidly spread to his bones...
Her name is Teresa Norris, but you can call her T.
Gregarious, down to earth and passionate about early detection, T. discovered a small lump in her breast during a self-exam in 2009. Seven years earlier, she had breast augmentation. Because implants can make it more difficult for doctors to find cancer, T. made regular breast self-exams part of her routine.
“If I hadn’t become an advocate for myself, I don’t know where I’d be,” she says. Caught at an early stage, her cancer is now in remission...
If retired art teacher Walter Stevens had painted a picture of his retirement 20 years ago, leukemia would not have been part of his palette. At 79, Stevens was diagnosed with Stage II chronic lymphocytic leukemia. But after 16 months of treatment, his prognosis couldn’t be better.
Stevens’ cancer was caught early, yet it was progressing rapidly and had certain high-risk indicators, suggesting it may not respond well to traditional chemotherapy, says Dr. Jeff Sharman...
At Willamette Valley Cancer Institute and Research Center, 42 clinical trials are currently under way to improve cancer care.
Each study tries to answer scientific questions and to find better ways to prevent, diagnose or treat cancer. As researchers test the effectiveness of the trial drugs, patients who participate, in many cases, benefit from life-saving treatment options years before they are available to the public...
An accurate cancer diagnosis is an integral part of planning for treatment. Patients who come to Willamette Valley Cancer Institute can now benefit from imaging technology new to Lane County and available at Oregon Imaging Centers, which was recently accredited for both oncological and neurological imaging procedures.
PET/CT exams are the most effective method for diagnosing or ruling out certain types of cancer, as well as coronary heart disease and brain disorders, such as Alzheimer’s and Parkinson’s diseases...
By targeting specific gene mutations, doctors can now use personalized medicine to treat cancer based upon unique features that caused it to grow.
Medical oncologist Dr. Jeff Sharman is helping lead the way in personalized medicine through research and clinical trials at Willamette Valley Cancer Institute and Research Center. Recently, he spoke at the Oregon Bioscience Association Conference about advances in cancer treatment.
“There are multiple ways a cancer can begin within a single part of the body,” Sharman says...
On Sunday, June 10, two front-page articles of The Register-Guard featured Willamette Valley Cancer Institute and Research Center.
"Fighting Cancer: Springfield doctor leads trials for breakthrough treatments" highlights clinical trials directed by Dr. Jeff Sharman...
Wow! What a wonderful turnout we had at Relay For Life of Eugene/Springfield. Words can’t begin to express the overwhelming joy we felt taking part in this fun, emotional and memorable event.
Friday night began with an opening ceremony, including remarks from our very own medical oncologist Dr. Jeff Sharman. He connected with everyone there, speaking directly from the heart with his inspiring words. Then, hundreds of survivors took to the track for the first lap, as the rest of us stood by cheering them on...
On Friday, Sept. 14, Siuslaw Bank will host its second annual Good Will Grill to raise money for the Leukemia & Lymphoma Society. Last year, the inaugural event raised $30,000 to fight blood cancers.
The event is organized by Siuslaw Bank employee Jeff Gusinow, who was diagnosed with follicular lymphoma in 2006. Since 2009, Willamette Valley Cancer Institute’s Dr. Jeff Sharman has been his oncologist. Learn more about Gusinow’s story here...
“I have leukemia, but I’m lucky,” says Betty Hemmingsen.
Diagnosed with chronic lymphocytic leukemia (CLL) in April 2011, Betty participated in a clinical trial at Willamette Valley Cancer Institute and Research Center. Sixteen months later, she learned her cancer was inactive...
Comfortably settled into an infusion chair in his preferred corner of the chemo suite, Jay Sperling smiles as he recounts the winding road he traveled to get here.
Back in 2002, when he was diagnosed with chronic lymphocytic leukemia (CLL), many of today’s treatments were unavailable. That’s the beauty of clinical trials, he notes, there’s always something new being developed and tested...
As if she’s preparing for a storm, Alicia Heer “watches and waits
” to see if her husband’s cancer will stay at bay or progress.
“It’s hard to accept not doing anything,” Alicia says. “Sometimes, I call it ‘wait and worry.’ We know something bad is inside of him, and we want it out. But there’s no way to eradicate it, and we don’t have control.”
It's an exciting time in cancer research, especially concerning chronic lymphocytic lymphoma (CLL). Dr. Jeff Sharman, Willamette Valley Cancer Institute and Research Center's research director, specializes in CLL and presented studies at the American Society of Hematology conference in December. Read more.
While in Atlanta for the conference, he sat down for an interview with Dr. Andrew Schorr of Patient Power to talk about CLL research and how the direction of treatment is changing, from traditional chemotherapy to targeted therapies...
Dr. Sharman is highlighted in this U.S. Oncology Network video focusing on his blood cancer research and his studies in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). Read more.
The first two chronic lymphocytic leukemia (CLL) patients ever in the world to receive a new, potentially life-saving drug for B-cell cancers were part of a clinical trial run by Dr. Jeff Sharman at WVCI. Read more.
Dr. Jeff Sharman, research director at WVCI, compares the remarkable advances in HIV medicines to the great strides in the treatment of blood cancers due to clinical trials. Read more.
Dr. Sharman shares a Focus Forward Films feature with Ross Kauffman discussing a new development for patients with B cell cancer. Read more.
Dr. Jeff Sharman, a hematologist oncologist at Willamette Valley Cancer Institute and Research Center, was published in the New England Journal of Medicine last week for clinical trials held at WVCI on a breakthrough drug for chronic lymphocytic leukemia (CLL). Read more.
Dr. Jeff Sharman, a hematologist oncologist at Willamette Valley Cancer Institute and Research Center, was recently interviewed in Cologne, Germany, about new drugs for chronic lymphocytic leukemia (CLL), and access to them through clinical trials. Read more.